Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
Pharmacoeconomics|February 15, 2015
Welfarism versus extra-welfarism: can the choice of economic evaluation approach impact on the adoption decisions recommended by economic evaluation studies?James Buchanan, Sarah Wordsworth
Pharmacoeconomics|November 20, 2019
A Review of Health Economic Studies Comparing Traditional and Massively Parallel Sequencing Diagnostic Pathways for Suspected Genetic DisordersPatrick Fahr, James Buchanan, Sarah Wordsworth
The Patient|May 12, 2016
Patients' Preferences for Genomic Diagnostic Testing in Chronic Lymphocytic Leukaemia: A Discrete Choice ExperimentJames Buchanan, Sarah Wordsworth, Anna Schuh
Applied Health Economics and Health Policy|April 4, 2019
A Review of the Challenges of Using Biomedical Big Data for Economic Evaluations of Precision MedicinePatrick Fahr, James Buchanan, Sarah Wordsworth
Pharmacogenomics|November 19, 2013
Issues surrounding the health economic evaluation of genomic technologiesJames Buchanan, Sarah Wordsworth, Anna Schuh
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 16, 2018
Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literatureKatharina Schwarze, James Buchanan, Jenny C Taylor, et al.
Pharmacoeconomics|August 19, 2021
What Aspects of Illness Influence Public Preferences for Healthcare Priority Setting? A Discrete Choice Experiment in the UKLiz Morrell, James Buchanan, Sian Rees, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 19, 2018
Valuation of Health and Nonhealth Outcomes from Next-Generation Sequencing: Approaches, Challenges, and SolutionsDean A Regier, Deirdre Weymann, James Buchanan, et al.
European Journal of Human Genetics : EJHG|June 1, 2026
The cost and cost-effectiveness of whole-exome and whole-genome sequencing: a systematic literature reviewFrederick McElwee, Sally L Sansom, James Buchanan, et al.
Gastrointestinal Endoscopy|September 9, 2017
Surgery versus surveillance in ulcerative colitis patients with endoscopically invisible low-grade dysplasia: a cost-effectiveness analysisBen Parker, James Buchanan, Sarah Wordsworth, et al.
Pageof 18